🔎 Trials Near Me

Home › Head and Neck Cancer › Missouri

Head and Neck Cancer clinical trials in Missouri

16 studies for Head and Neck Cancer are looking for participants at sites in Missouri.

Cities in Missouri

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site #0114, St Louis
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478

Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery

  • Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07848841

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • Washington University, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06657222

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

  • Washington University in St. Louis, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05442957

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

  • Washington University School of Medicine, St Louis
RecruitingObservational study
Ages 18 to 50 · Women · Updated Sep 2, 2026 · NCT06904365

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06910657

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Saint Luke's Cancer Institute, Kansas City
  • Washington University, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Saint Louis University, St Louis
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Jul 6, 2026 · NCT06710756

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - SPG, Springfield
  • Mercy Hospital - South, St Louis
  • Mercy Hospital -STL, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07327489

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Washington University Infusion Center Pharmacy, St Louis
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT06256588

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT04354064

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

  • Washington University in St. Louis, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT05793151

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

  • University of Missouri, Columbia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 17, 2024 · NCT04444869

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.